Abstract:Characteristics of neonates with pulmonary atresia and intact ventricular septum predict type of definitive repair. A morphologically driven institutional protocol emphasizing both 2-ventricle and Fontan pathways might mitigate the negative effect of unfavorable morphology. In the current era, 85% of neonates are likely to reach a definitive surgical end point, with 2-ventricle repair achieved in an estimated 50%.
“…The success of heart transplantation as a therapy for hypoplastic left heart syndrome led pediatric transplantation centers to apply heart transplantation as primary therapy in other conditions for which there was a poor natural history with standard surgical therapy. These conditions have included pulmonary atresia with intact septum and right ventricledependent coronary circulation 54,55 and complex heterotaxy syndromes 56,57 in which a functional single ventricle can be associated with anomalous pulmonary venous return and severe atrioventricular or semilunar valve disease.…”
Backgroundâ
Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure.
Methods and Resultsâ
A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed.
Conclusionsâ
This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.
“…The success of heart transplantation as a therapy for hypoplastic left heart syndrome led pediatric transplantation centers to apply heart transplantation as primary therapy in other conditions for which there was a poor natural history with standard surgical therapy. These conditions have included pulmonary atresia with intact septum and right ventricledependent coronary circulation 54,55 and complex heterotaxy syndromes 56,57 in which a functional single ventricle can be associated with anomalous pulmonary venous return and severe atrioventricular or semilunar valve disease.…”
Backgroundâ
Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure.
Methods and Resultsâ
A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed.
Conclusionsâ
This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.
“…6 In extreme cases, the entire intrapericardial pulmonary arterial tree is absent and blood is supplied to the lungs by collateral arteries only. Some patients may be amenable to surgical repair 7, 8, 9. âUnifocalizationâ is a staged approach aimed at reconstructing the PAs and perfusing them by means of modified BlalockâTaussig shunts with the ipsilateral subclavian arteries, or with other shunts as dictated by specific PA anatomy.…”
Section: Conditions In Which Segmental Ph May Developmentioning
confidence: 99%
“…The lung supplied by a normalâsized, unobstructed PA originating from the aorta is typically pressure and volume overloaded early in life and pulmonary vascular disease develops. Mortality is high in the first year of life (up to 70%) without timely repair 7. A small proportion of unrepaired patients do survive to adulthood and beyond, with segmental (eg, unilateral) PH.…”
Section: Conditions In Which Segmental Ph May Developmentioning
“…53,54 Lower mortality in the current era may reflect (1) better selection of patients to decompress and attempt a biventricular repair, (2) the recognition of overcirculation and coronary steal in the initial palliation, and (3) the incorporation of transplantation as one of the therapeutic options. [55][56][57][58] With the overall survival having improved, the most practical approach may be to study the coronary circulation on diagnosis of those with a small tricuspid valve annulus, because it is now apparent that an RV-dependent coronary circulation typically exists in the hypoplastic RV unsuitable for biventricular repair. If an RV-dependent coronary circulation exists in an asymptomatic patient with normal left ventricular function and wall motion, then a reasonable option is to proceed with palliative surgery with a systemic-to-PA shunt with postoperative management that minimizes overcirculation, followed by early placement of a bidirectional cavopulmonary shunt and a Fontan procedure.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.